My mother, who is almost 71 years old, was diagnosed 4 years ago with multiple myeloma. At the peak, her IgG level was 4100, with damage to the bones (no damage to kidney).
Her treatment so far:
- Bortezomib (Velcade); duration: 6 months
- No medication; duration: 12 months
- Lenalidomide (Revlimid); duration: 30 months (stable IgG level at: 1700)
- Daratumumab (Darzalex), duration: 2 months (ongoing) (IgG 2500, free kappa 60)
We have a few options available from the medical insurance.
Can you recommend on which single / combination of medicine to continue with?
Thanks,
Liran.